Back to company

MACURE PHARMA ApS: Financial statements 2019

CVR: 35234748

MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 16,325,244 and a net result of DKK 9,187,713 compared with DKK 5,335,423 the year before. That is an increase of 59.2% compared with the year before. Equity amounted to DKK 14,194,393. The solvency ratio was 32.2%. The company had 6 employees in the financial year.

Gross Profit
16,325,244 kr.
Profit/Loss
9,187,713 kr.
Equity
14,194,393 kr.
Total Assets
44,046,076 kr.
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-16.3 mio.9.2 mio.14.2 mio.6
2018-10.3 mio.5.3 mio.10.5 mio.5
2017-14.4 mio.8.9 mio.12 mio.4
2016-13.3 mio.9.1 mio.5.5 mio.-
2015-680 t.407 t.823 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

MACURE PHARMA ApS: The 2018 annual report is outMay 29, 2019

MACURE PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 10,257,349, and the net result was DKK 5,335,423.

About MACURE PHARMA ApS

MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity amounted to DKK 18,033,649.